Share this article on:

A Framework for Evidence Evaluation and Methodological Issues in Implantable Device Studies

Sedrakyan, Art MD, PhD*; Marinac-Dabic, Danica MD, PhD*; Normand, Sharon-Lise T. PhD†; Mushlin, Alvin MD, ScM‡; Gross, Tom MD, MPH*

doi: 10.1097/MLR.0b013e3181d991c4
Comparative Effectiveness

Implantable medical devices (IMD) are frequently used in interventional medicine. There are a host of complex methodological issues to consider in conducting device studies. A general conceptual framework for evidence evaluation is needed to help investigators conduct comparative studies in this setting. It is known that clinical trials of implants require study design planning and creative execution that are quite different from those in pharmaceutical setting. Important study design issues such as randomization, masking and allocation concealment require unique approaches for each device. In addition, device comparative studies must cope with sources of variability different from pharmaceutical studies. These include operator learning curve effects, hospital-operator-patient interactions, and issues related to device technical characteristics. Observational studies of IMDs are particularly challenging. Selection of comparison groups, adjusting for confounding and addressing learning curve issues needs careful planning. We propose a general framework for IMD evaluation and provide an outline of the methodological issues that require further discussion. We hope this article will inspire and help to inform those interested in advancing comparative safety and effectiveness of IMDs and to plan and pursue future methodological work in this area.

From the *Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD; †Department of Health Care Policy, Harvard Medical School and Harvard School of Public Health, Boston, MA; and ‡Department of Public Health, Weill Medical College of Cornell University, New York, NY.

Presented at the AHRQ Methods for Comparative Effectiveness Conference 2009, Rockville, MD.

The opinions expressed in this article are those of the authors and not necessarily those of the Food and Drug Administration.

Reprints: Art Sedrakyan, MD, PhD, WO Bldg 66 - Room 3115, Center for Devices and Radiological Health, FDA, 10903 New Hampshire Av., Silver Spring, MD 20993-0002. E-mail: art.sedrakyan@fda.hhs.gov or asedraky@jhsph.edu.

© 2010 Lippincott Williams & Wilkins, Inc.